Peptide vaccines for pediatric high-grade glioma and diffuse midline glioma: Current progress and future perspectives

Authors

Aron K Mebrahtu, Duke University
Vatsal Jain, Duke University
Eliese M Moelker, Duke University
Alexandra M Hoyt-Miggelbrink, Duke University
Katayoun Ayasoufi, Duke University
Eric M Thompson, Washington University School of Medicine in St. Louis

Journal

Vaccines

Publication Date

11-30-2025

Volume

13

Issue

12

First Page

1215

Document Type

Open Access Publication

DOI

10.3390/vaccines13121215

Rights and Permissions

Mebrahtu AK, Jain V, Moelker EM, Hoyt-Miggelbrink AM, Ayasoufi K, Thompson EM. Peptide Vaccines for Pediatric High-Grade Glioma and Diffuse Midline Glioma: Current Progress and Future Perspectives. Vaccines (Basel). 2025 Nov 30;13(12):1215. doi: 10.3390/vaccines13121215 Copyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/ licenses/by/4.0/).

Recommended Citation

Mebrahtu, Aron K; Jain, Vatsal; Moelker, Eliese M; Hoyt-Miggelbrink, Alexandra M; Ayasoufi, Katayoun; and Thompson, Eric M, "Peptide vaccines for pediatric high-grade glioma and diffuse midline glioma: Current progress and future perspectives." Vaccines. 13, 12. 1215 (2025).
https://digitalcommons.wustl.edu/oa_4/6139